August 2026
1. DECANTER C, Legrand C, Behal H, Mailliez A, et al
   Pre-treatment AMH levels suggesting PCOM do not prevent chemotherapy-induced ovarian damage despite higher long-term ovarian reserve: a longitudinal study in 467 women treated with alkylating agents.
   Hum Reprod. 2026 Aug 14:deag131. doi: 10.1093.
   

   >> Share

   
   April 2026
2. BERLANDA N, Bandini V, Croci GA, Dridi D, et al
   Histological and immunohistochemical characteristics of superficial peritoneal endometriotic lesions of clinical responders and non-responders to dienogest treatment.
   Hum Reprod. 2026 Apr 18:deag059. doi: 10.1093.
   

   >> Share

   
   April 2025
3. 
   Correction to: Endometriosis and risk of depression among oral contraceptive users: a pooled analysis of cohort studies from 13 countries.
   Hum Reprod. 2025 Apr 3:deaf065. doi: 10.1093.
   

   >> Share

   
   January 2025
4. DE CORTE P, Milhoranca I, Oberg AS, Kurth T, et al
   Endometriosis and risk of depression among oral contraceptive users: a pooled analysis of cohort studies from 13 countries.
   Hum Reprod. 2025 Jan 12:deae299. doi: 10.1093.
   

   >> Share

   
   October 2024
5. OKTEM O, Esmaeilian Y, Iltumur E, Yusufoglu S, et al
   Exposure of antral follicles to medroxyprogesterone acetate during stimulation does not cause molecular perturbations in gonadotropin-responsiveness and steroidogenic function of granulosa cells in progestin-primed cycles.
   Hum Reprod. 2024;39:2331-2340.
   

   >> Share

   
   April 2024
6. DONNEZ J, Becker C, Taylor H, Carmona Herrera F, et al
   Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
   Hum Reprod. 2024 Apr 22:deae076. doi: 10.1093.
   

   >> Share

   
   December 2023
7. LORETI S, Thiele K, De Brucker M, Olsen C, et al
   Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.
   Hum Reprod. 2023 Dec 18:dead256. doi: 10.1093.
   

   >> Share

   
   November 2023
8. VERCELLINI P, Bandini V, Vigano P, Ambruoso D, et al
   Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions.
   Hum Reprod. 2023 Nov 10:dead206. doi: 10.1093.
   

   >> Share

   
   
9. FAN G, Liu Q, Bi J, Qin X, et al
   Association between female-specific reproductive factors and leukocyte telomere length.
   Hum Reprod. 2023;38:2239-2246.
   

   >> Share

   
   June 2023
10. OLTMAN J, Balachander S, Mol BW, Woolner AMF, et al
    Have we overlooked the role of mifepristone for the medical management of tubal ectopic pregnancy?
    Hum Reprod. 2023 Jun 9:dead116. doi: 10.1093.
    

    >> Share

    
    
11. SAKULPAISAL M, Sothornwit J, Somboonporn W
    The effects of exogenous estrogen in women with SAR-CoV-2 infection: a systematic review and meta-analysis.
    Hum Reprod. 2023;38:1111-1123.
    

    >> Share

    
    April 2023
12. CANIS M, Guo SW
    In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain.
    Hum Reprod. 2023 Apr 6:dead061. doi: 10.1093.
    

    >> Share

    
    
13. JEON H, Choi Y, Brannstrom M, Akin JW, et al
    Cortisol/glucocorticoid receptor: a critical mediator of the ovulatory process and luteinization in human periovulatory follicles.
    Hum Reprod. 2023;38:671-685.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share